VANCOUVER, Aug. 16, 2019 /PRNewswire/ – 1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF), a vertically integrated cannabis consumer packaged goods company, announces the grant of 6,800,000 incentive stock options to its directors, officers, consultants and employees pursuant to the Company’s stock option plan. The options are exercisable for a period of three years at a price of $0.35 per share and will vest over a three-year period.
Further to the Company’s announcement that it would hold a meeting of debenture holders holding 10% unsecured convertible debentures with an expiry date of September 14, 2021(“Debentures”), the Company has determined not to pursue the amendment to the Debentures and is therefore cancelling the meeting scheduled for August 28, 2019. The payment of interest will be made in cash.
The Company reminds holders of warrants expiring on August 16, 2019 of the deadline today.
About 1933 Industries Inc.
1933 Industries Inc. is a vertically integrated, brand-focused cannabis company with operations in the United States and Canada. Operating through two subsidiary companies, the Company owns leading cannabis brands as well as licensed cannabis cultivation, extraction, processing and manufacturing assets. With the goal of delivering natural wellness, our award-winning proprietary portfolio of brands include: AMA flower and AMA concentrates, CBD-infused Canna Hemp™, Canna Hemp X™, and Canna Fused™. Partners under licensing agreements include Denver Dab Co., Birdhouse Skateboards™, Gotti’s Gold and Kurupt Moonrocks. The Company owns 91% of Alternative Medicine Association, LC (AMA), and 100% of Infused MFG.
About Canna Hemp™
Canna Hemp™ CBD Relief Cream was named “Best Topical” by Leafy’s Best in State: The Top State Specific Products and Experiences of 2018.
About Canna HempX™
Canna Hemp X™ was named “Best Topicals for Pain” by Herb’s Guide to the Best Cannabis Products on the Planet. Canna Hemp X™ is a CBD sports recovery cream for athletes, bridging the gap between recovery and top performance.
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that